The burgeoning market for GLP-1 weight-loss medications created a gold rush for telehealth companies, but for Hims & Hers, a bold move into this lucrative space has rapidly devolved into a multi-front battle with regulators and pharmaceutical giants. The company's recent announcement that it would
With a deep background in biopharmaceutical research and development, Ivan Kairatov has a keen eye for innovations that could reshape how we treat the most challenging cancers. Today, he joins us to discuss a promising new preclinical study on pancreatic ductal adenocarcinoma (PDAC), a notoriously
The quiet aftermath of a traumatic event often conjures images of panicked awakenings and a constant state of high alert, yet for the vast majority of survivors, the most debilitating struggle is a silent, internal battle waged not against terror but against a crushing weight of sorrow and
The integration of artificial intelligence into healthcare has promised to revolutionize diagnostics and patient care, yet a groundbreaking study from the Mount Sinai Health System reveals a critical vulnerability that could undermine this progress. Extensive testing on large language models (LLMs)
The landscape of modern medicine is undergoing a profound transformation, shifting from a reactive model of treating symptoms to a proactive strategy focused on early detection and prevention. This evolution is fueling an unprecedented surge in advanced diagnostic technologies, with whole body
Mapping the incredibly dense and complex network of neural pathways within the human brainstem has long been one of the most formidable challenges in neuroimaging, but the emergence of sophisticated artificial intelligence is finally pulling this critical region out of the shadows. Artificial
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66
